色播婷婷电影综合社区,AV女优不卡亚洲在线,99999AV,日韩人妻中文字幕视频,国产拍自偷,91人人妻,超碰在线81,免费福利视频一区,九草青草原在线看

Liaoning Aoda Pharmaceutical Co., Ltd., established in 1996, is located in Yingkou, Liaoning—a coastal city in China with well-developed land, sea, and air transportation. The company is a comprehensive pharmaceutical enterprise integrating research, production, and operation, engaged in a wide range of products including pharmaceutical excipients, active pharmaceutical ingredients (APIs), solid preparations, food additives, and biochemical products.

The pharmaceutical excipients mainly include 17 product specifications such as low-substituted hydroxypropyl cellulose, microcrystalline cellulose, sodium carboxymethyl starch, magnesium stearate, pregelatinized starch, and dextrin. Oral preparations include 42 varieties such as the innovative drug Mudan Granules, Compound Bismuth Aluminate Granules, Pediatric Cough and Asthma Effervescent Tablets, and Compound Motherwort Tablets.

The company has an annual production capacity of over ten thousand tons of pharmaceutical raw materials and excipients. Its product standards for pharmaceutical raw materials and excipients are aligned with international standards. In 2001, it became one of the first in China to pass GMP certification for pharmaceutical excipients, traditional Chinese medicine, and solid preparations. The quality standards comply with CP, USP, BP, EP, JP, GB, and others. The company has introduced advanced domestic and international production, research, testing equipment, and technologies, and adheres to GMP (Good Manufacturing Practice) to ensure product quality.

As a core global supplier, the company provides pharmaceutical excipients and technical services to international pharmaceutical companies on a long-term basis, establishing extensive and friendly cooperative relationships with clients both domestically and internationally. Currently, its marketing network covers Europe, America, Southeast Asia, and other countries, as well as all thirty provinces, municipalities, and autonomous regions across China.